$148.29–$161.18
Q4182 identifies the TransCyte product by square centimeters; 15271 reports the primary skin-substitute application procedure for its site and area grouping.
On this page
CMS RVU26D · Effective 2026-10-01
Q4182 Skin substitute Medicare reimbursement rates in Georgia
Report Q4182 for TransCyte used as a temporary skin covering, with the primary skin-substitute application procedure and units based on square centimeters. Compare Q4182 office and facility rates across CMS payment localities in Georgia.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for Q4182 in Georgia?
Georgia has 2 payment localities in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the 2 payment areas shown below, using the same CMS release.
Office / nonfacility
$113.51–$129.29
2 of 2 localities have a supported rate.
Facility setting
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Wound care product
About Q4182: TransCyte skin substitute, per square centimeter
Report Q4182 for TransCyte used as a temporary skin covering, with the primary skin-substitute application procedure and units based on square centimeters.
Q4182 identifies TransCyte, a temporary skin substitute used to cover wounds, including burn wounds and donor sites. Burn surgeons and other clinicians performing wound care may use it during treatment that applies a skin substitute to the affected area. The product code represents the TransCyte material; the related application procedure describes the work of placing the substitute on the wound.
Report Q4182 only with a primary procedure, not as a stand-alone service. Select the primary application code for the treated site and wound area, and document the wound location, treated area, product used, and quantity in square centimeters. CMS classifies Q4182 as an add-on code paid within the primary procedure's global period. It is technical-component-only; a separate code covers interpretation.
CMS billing rules for Q4182
- Global period
- Add-on code: billed only together with a primary procedure and paid within that procedure's global period.
- Professional and technical components
- Technical-component-only code: a separate code covers interpretation.
Where the value comes from
- Work RVU0.00 · 0%
- Practice expense (office) RVU3.81 · 100%
- Malpractice RVU0.00 · 0%
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Q4182 compared with similar codes
Office rates for Georgia, from the same CMS release.
$305.72–$329.49
Q4182 identifies TransCyte material. Use 15273 for the primary application procedure when the wound falls within that code's site grouping rather than 15271's.
$113.51–$129.29
Q4183 identifies Surgigraft rather than TransCyte. Select the product code that matches the material actually used.
Compare Q4182 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
2 of 2 payment localities
Atlanta →
Office / nonfacility
$129.29
Facility
Unavailable
Rest Of Georgia →
Office / nonfacility
$113.51
Facility
Unavailable
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
Q4182 billing questions
Can Q4182 be billed by itself?
No. CMS classifies it as an add-on code that must be reported with a primary procedure.
Which application code should accompany Q4182?
Choose the primary skin-substitute application code that fits the wound site and treated area. For example, 15271 and 15273 cover different site groupings.
How should the units be determined?
The descriptor is per square centimeter. Document the treated area and the quantity of TransCyte reported.
Does Q4182 include interpretation?
No. CMS identifies Q4182 as technical-component-only and assigns interpretation to a separate code.
What documentation supports Q4182?
Record the wound location and area, the TransCyte product used, the quantity in square centimeters, and the associated primary application procedure.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
18,271Q4179,,"Flowerderm, per sq cm",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,272Q4180,,"Revita, per sq cm",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,273Q4181,,"Amnio wound, per square cm",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,274Q4182,,"Transcyte, per sq centimeter",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,275Q4183,,"Surgigraft, 1 sq cm",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,276Q4184,,Cellesta or duo per sq cm,A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,277Q4185,,Cellesta flowab amnion 0.5cc,C,,0.00,0.00,,0.00,,0.00,0.00,0.00,3,XXX,0.00,0.00,0.00,9,9,9,9,9,9,,33.4009,09,0,99,0.00,0.00,0.00